Attached files

file filename
EX-99.3 - EXHIBIT 99.3 - BioCardia, Inc.ex99-3.htm
EX-99.2 - EXHIBIT 99.2 - BioCardia, Inc.ex99-2.htm
EX-99.1 - EXHIBIT 99.1 - BioCardia, Inc.ex99-1.htm
EX-10.8 - EXHIBIT 10.8 - BioCardia, Inc.ex10-8.htm
EX-10.7 - EXHIBIT 10.7 - BioCardia, Inc.ex10-7.htm
EX-10.6 - EXHIBIT 10.6 - BioCardia, Inc.ex10-6.htm
EX-10.5 - EXHIBIT 10.5 - BioCardia, Inc.ex10-5.htm
EX-10.4 - EXHIBIT 10.4 - BioCardia, Inc.ex10-4.htm
EX-10.3 - EXHIBIT 10.3 - BioCardia, Inc.ex10-3.htm
EX-10.2 - EXHIBIT 10.2 - BioCardia, Inc.ex10-2.htm
EX-10.1 - EXHIBIT 10.1 - BioCardia, Inc.ex10-1.htm
EX-4.1 - EXHIBIT 4.1 - BioCardia, Inc.ex4-1.htm
EX-3.2 - EXHIBIT 3.2 - BioCardia, Inc.ex3-2.htm
EX-3.1 - EXHIBIT 3.1 - BioCardia, Inc.ex3-1.htm
EX-2.2 - EXHIBIT 2.2 - BioCardia, Inc.ex2-2.htm
8-K - FORM 8-K - BioCardia, Inc.bioc20161019_8k.htm

Exhibit 16.1

 

 

 

October 27, 2016

 

U.S. Securities and Exchange Commission

Office of the Chief Accountant

100F Street Northeast

Washington, DC 20549-2000

 

RE:

TIGER X MEDICAL, INC.

  File No. 000-21419

 

Dear Sir or Madam:

 

We have read Item 4.01 of Form 8-K dated October 27, 2016 of TIGER X MEDICAL, INC. (“the Registrant”) and are in agreement with the statements contained therein as it pertains to our firm.

 

We have no basis to agree or disagree with any other statements of the Registrant contained in Item 4.01.

 

Sincerely,                          

 

/s/ Anton & Chia, LLP

 

 

Page 1 of 1